Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension ; volume:41 ; number:3 ; day:10 ; month:1 ; year:2024 ; pages:1062-1074 ; date:3.2024
Advances in therapy ; 41, Heft 3 (10.1.2024), 1062-1074, 3.2024

Classification: Medizin, Gesundheit

Creator: Barberà, Joan
Jansa, Pavel
Klings, Elizabeth
Ristić, Arsen
Keogh, Anne
Solum, Derek
Rao, Youlan
Grover, Rob
Saib, Isil
Sood, Namita

Contributor: SpringerLink (Online service)

DOI: 10.1007/s12325-023-02769-7

URN: urn:nbn:de:101:1-2404291048162.801393283648

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Barberà, Joan
Jansa, Pavel
Klings, Elizabeth
Ristić, Arsen
Keogh, Anne
Solum, Derek
Rao, Youlan
Grover, Rob
Saib, Isil
Sood, Namita
SpringerLink (Online service)

Other Objects (12)

Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study

Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension

Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension

Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension

Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study) : An Open-Label Observational Study

Arterial hypertension

Long-Term Safety and Efficacy of Macitentan in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from MERIT and its Open-Label Extension

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study

Pulmonary arterial hypertension

Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension

Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents

Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study

Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study

Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension

Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension

Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension

Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study) : An Open-Label Observational Study

Arterial hypertension

Long-Term Safety and Efficacy of Macitentan in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from MERIT and its Open-Label Extension

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study

Pulmonary arterial hypertension

Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension

Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents

Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study

Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study

Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension

Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension

Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension

Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study) : An Open-Label Observational Study

Arterial hypertension

Long-Term Safety and Efficacy of Macitentan in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from MERIT and its Open-Label Extension

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study

Pulmonary arterial hypertension

Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension

Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents

Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study

Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension

Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension

Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension

Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study) : An Open-Label Observational Study

Arterial hypertension

Long-Term Safety and Efficacy of Macitentan in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from MERIT and its Open-Label Extension

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study

Pulmonary arterial hypertension

Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension

Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents

Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study

Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study

Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension

Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension

Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension

Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study) : An Open-Label Observational Study

Arterial hypertension

Long-Term Safety and Efficacy of Macitentan in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from MERIT and its Open-Label Extension

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study

Pulmonary arterial hypertension

Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension

Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents

Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study

Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study

Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension

Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension

Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension

Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study) : An Open-Label Observational Study

Arterial hypertension

Long-Term Safety and Efficacy of Macitentan in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from MERIT and its Open-Label Extension

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study

Pulmonary arterial hypertension

Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension

Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents

Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study

Related objects

Reset password